Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C10H20O |
| Molecular Weight | 156.2652 |
| Optical Activity | ( - ) |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
InChI
InChIKey=NOOLISFMXDJSKH-KXUCPTDWSA-N
InChI=1S/C10H20O/c1-7(2)9-5-4-8(3)6-10(9)11/h7-11H,4-6H2,1-3H3/t8-,9+,10-/m1/s1
| Molecular Formula | C10H20O |
| Molecular Weight | 156.2652 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/18640220https://www.drugbank.ca/drugs/DB00825https://www.google.com/patents/WO1996014840A1Curator's Comment: description was created based on several sources, including:
http://www.tera.org/OARS/Menthol%20WEEL%20FINAL.pdf | http://www.inchem.org/documents/sids/sids/MENTHOLS.pdf
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18640220https://www.drugbank.ca/drugs/DB00825https://www.google.com/patents/WO1996014840A1
Curator's Comment: description was created based on several sources, including:
http://www.tera.org/OARS/Menthol%20WEEL%20FINAL.pdf | http://www.inchem.org/documents/sids/sids/MENTHOLS.pdf
Menthyl lactate is derived from menthol, a compound that comes from peppermint oil, or is made synthetically. Menthol has a natural cooling effect, which makes it useful as a topical analgesic to treat skin irritation, pain, itching or sunburn. Despite its cooling benefits, menthol can be a skin irritant. Like menthol, menthyl lactate is cooling, but it causes less skin irritation than menthol. Menthyl lactate also has a refreshing, minty taste. For this reason, some manufacturers use it as a flavoring ingredient. The compound is recommended for use as a flavor in concentrations of 0.005% to 0.2% and in cosmetic and other external products in concentrations ranging from 0.2% to 2.0%. Menthyl lactate is a known compound available e.g. from Haarmann & Reimer GmbH (Germany) under the name FRESCOLAT, Type ML.
Originator
Sources: http://www.reboundhealth.com/cms/images/pdf/Textbooks/menthol%20id%2015852.pdfhttps://books.google.ru/books?id=DbO4CQAAQBAJ&pg=PA98&lpg=PA98&dq=Gaubius+menthol&source=bl&ots=ft5FpITBM9&sig=NQbFKhTehMQ4Oyy2Qz9DP_leqFk&hl=ru&sa=X&ved=0ahUKEwjC4bGHoP7SAhXLWSwKHY4kADk4ChDoAQggMAE#v=onepage&q=Gaubius%20menthol&f=falsehttps://www.google.com/patents/DE2608226A1
Curator's Comment: reference retrieved from http://www.leffingwell.com/MBE-SFC-Coolants.pdf | http://www.leffingwell.com/download/Leffingwell%20-%20Handbook%20of%20Cosmetic%20Science%20and%20Technology.pdf
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL5282 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18640220 |
37.8 µM [IC50] | ||
Target ID: CHEMBL340 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18640220 |
300.0 µM [IC50] | ||
Target ID: Q7Z2W7 Gene ID: 79054.0 Gene Symbol: TRPM8 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/16829128 |
30.0 µM [EC50] | ||
Target ID: O75762 Gene ID: 8989.0 Gene Symbol: TRPA1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/16829128 |
68.0 µM [IC50] | ||
Target ID: P41145 Gene ID: 4986.0 Gene Symbol: OPRK1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/11897159 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Palliative | BENGAY Approved Usetemporarily relieves the minor aches and pains of muscles and joints associated with a simple backache, arthritis, strains, bruises, sprains. |
|||
| Palliative | BENGAY Approved Usetemporarily relieves the minor aches and pains of muscles and joints associated with a simple backache, arthritis, strains, bruises, sprains. |
|||
| Palliative | Unknown Approved UseUnknown |
|||
| Palliative | VICKS VAPORUB Approved UseOn chest and throat, temporarily relieves cough due to common cold |
|||
| Primary | VICKS VAPORUB Approved UseOn muscles and joints, temporarily relieves minor aches and pains |
|||
| Primary | CVS ANTI ITCH Approved UseFor the temporary relief of pain and itching associated with minor skin irritations such as poison ivy/oak/sumac, sunburn, insect bites and minor cuts and scrapes. |
|||
| Palliative | VICKS VAPORUB Approved UseTreatment for rhinitis that is associated with acute upper respiratory tract infection and allergy |
|||
| Palliative | Unknown Approved UseUnknown |
|||
Sources: https://www.google.com/patents/WO1996014840A1 |
Primary | FRESCOLAT ML Approved UseThe compund is uses as a flavoring ingredient and in cosmetics as a cooling agent |
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
32.89 ng/mL |
80 mg single, intragastric dose: 80 mg route of administration: Intragastric experiment type: SINGLE co-administered: |
LEVOMENTHOL plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
31.6 ng/mL |
160 mg single, intragastric dose: 160 mg route of administration: Intragastric experiment type: SINGLE co-administered: |
LEVOMENTHOL plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
48 ng/mL |
320 mg single, intragastric dose: 320 mg route of administration: Intragastric experiment type: SINGLE co-administered: |
LEVOMENTHOL plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
5617.46 ng/mL |
80 mg single, intragastric dose: 80 mg route of administration: Intragastric experiment type: SINGLE co-administered: |
MENTHOL GLUCURONIDE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
9882.69 ng/mL |
160 mg single, intragastric dose: 160 mg route of administration: Intragastric experiment type: SINGLE co-administered: |
MENTHOL GLUCURONIDE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
17601.81 ng/mL |
320 mg single, intragastric dose: 320 mg route of administration: Intragastric experiment type: SINGLE co-administered: |
MENTHOL GLUCURONIDE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
45.46 ng × h/mL |
80 mg single, intragastric dose: 80 mg route of administration: Intragastric experiment type: SINGLE co-administered: |
LEVOMENTHOL plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
52.64 ng × h/mL |
160 mg single, intragastric dose: 160 mg route of administration: Intragastric experiment type: SINGLE co-administered: |
LEVOMENTHOL plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
109.34 ng × h/mL |
320 mg single, intragastric dose: 320 mg route of administration: Intragastric experiment type: SINGLE co-administered: |
LEVOMENTHOL plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
9676.67 ng × h/mL |
80 mg single, intragastric dose: 80 mg route of administration: Intragastric experiment type: SINGLE co-administered: |
MENTHOL GLUCURONIDE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
15639.85 ng × h/mL |
160 mg single, intragastric dose: 160 mg route of administration: Intragastric experiment type: SINGLE co-administered: |
MENTHOL GLUCURONIDE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
32115.5 ng × h/mL |
320 mg single, intragastric dose: 320 mg route of administration: Intragastric experiment type: SINGLE co-administered: |
MENTHOL GLUCURONIDE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
1.0306 h |
80 mg single, intragastric dose: 80 mg route of administration: Intragastric experiment type: SINGLE co-administered: |
LEVOMENTHOL plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
1.7739 h |
160 mg single, intragastric dose: 160 mg route of administration: Intragastric experiment type: SINGLE co-administered: |
LEVOMENTHOL plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
1.222 h |
320 mg single, intragastric dose: 320 mg route of administration: Intragastric experiment type: SINGLE co-administered: |
LEVOMENTHOL plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
7.8072 h |
80 mg single, intragastric dose: 80 mg route of administration: Intragastric experiment type: SINGLE co-administered: |
MENTHOL GLUCURONIDE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
5.5689 h |
160 mg single, intragastric dose: 160 mg route of administration: Intragastric experiment type: SINGLE co-administered: |
MENTHOL GLUCURONIDE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
5.8693 h |
320 mg single, intragastric dose: 320 mg route of administration: Intragastric experiment type: SINGLE co-administered: |
MENTHOL GLUCURONIDE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
Funbound
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
15.3% |
LEVOMENTHOL plasma | Homo sapiens |
Doses
| Dose | Population | Adverse events |
|---|---|---|
3 % single, topical Studied dose |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
Other AEs: Swelling of limbs... |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Swelling of limbs | 1 pt | 3 % single, topical Studied dose |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
Overview
| CYP3A4 | CYP2C9 | CYP2D6 | hERG |
|---|---|---|---|
OverviewOther
| Other Inhibitor | Other Substrate | Other Inducer |
|---|---|---|
Drug as perpetrator
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 1.0 |
no [IC50 5.1153 uM] | |||
Page: 15.0 |
no | |||
Page: 47.0 |
no | |||
Page: 46.0 |
no | |||
Page: 46.0 |
no | |||
Page: 47.0 |
no | |||
| weak [IC50 1215 uM] | ||||
| weak [IC50 1419 uM] | ||||
| weak [IC50 202 uM] | ||||
| weak [IC50 343 uM] | ||||
| weak [IC50 995 uM] |
Drug as victim
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
| yes [Km 1900 uM] | ||||
| yes [Km 330 uM] | ||||
| yes [Km 370 uM] | ||||
| yes [Km 760 uM] | ||||
| yes [Km 800 uM] |
Tox targets
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 46.0 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effects of d-menthol stress on the growth of and microcystin release by the freshwater cyanobacterium Microcystis aeruginosa FACHB-905. | 2014-10 |
|
| Different effects of l- and d-menthol on the microstructure of ceramide 5/cholesterol/palmitic acid bilayers. | 2010-12-15 |
|
| Fragrance material review on d-menthol. | 2008-11 |
|
| Characterization of the mouse cold-menthol receptor TRPM8 and vanilloid receptor type-1 VR1 using a fluorometric imaging plate reader (FLIPR) assay. | 2004-02 |
|
| Characterization of essential oils from lamiaceae species by fourier transform Raman spectroscopy. | 2002-09-25 |
|
| Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo. | 2002-09 |
|
| Cold- and menthol-sensitive C afferents of cat urinary bladder. | 2002-08-15 |
|
| Voltage-dependent block of neuronal and skeletal muscle sodium channels by thymol and menthol. | 2002-08 |
|
| Phytochemical induction by herbivores could affect quality of essential oils from aromatic plants. | 2002-07-03 |
|
| Antimicrobial screening of Mentha piperita essential oils. | 2002-07-03 |
|
| A novel treatment of postherpetic neuralgia using peppermint oil. | 2002-06-06 |
|
| Preparation and self-assembly of chiral porphyrin diads on the gold electrodes of quartz crystal microbalances: a novel potential approach to the development of enantioselective chemical sensors. | 2002-06-03 |
|
| Field evaluation of three plant-based insect repellents against malaria vectors in Vaca Diez Province, the Bolivian Amazon. | 2002-06 |
|
| Mentholated cigarettes and smoking cessation: findings from COMMIT. Community Intervention Trial for Smoking Cessation. | 2002-06 |
|
| Ion channels activated by cold and menthol in cultured rat dorsal root ganglion neurones. | 2002-05-17 |
|
| [TRP channels--sensitive for heat and cold, capsaicin and menthol]. | 2002-05-16 |
|
| Anti-HIV activity of thiosemicarbazone and semicarbazone derivatives of (+/-)-3-menthone. | 2002-05 |
|
| Insecticidal properties of essential plant oils against the mosquito Culex pipiens molestus (Diptera: Culicidae). | 2002-05 |
|
| Analysis of menthol in three traditional Chinese medicinal herbs and their compound formulation by GC-MS. | 2002-05 |
|
| Extraction of thymol, eucalyptol, menthol, and camphor residues from honey and beeswax. Determination by gas chromatography with flame ionization detection. | 2002-04-19 |
|
| Menthol: a natural analgesic compound. | 2002-04-12 |
|
| An analysis of the mainstream smoke chemistry of samples of the U.S. cigarette market acquired between 1995 and 2000. | 2002-04 |
|
| A chlorinated monoterpene ketone, acylated beta-sitosterol glycosides and a flavanone glycoside from Mentha longifolia (Lamiaceae). | 2002-04 |
|
| Signal transduction. Hot and cold TRP ion channels. | 2002-03-22 |
|
| Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. | 2002-03-20 |
|
| Essential oil composition of sachalinmint from Norway detected by solid-phase microextraction and gas chromatography-mass spectrometry analysis. | 2002-03-13 |
|
| A TRP channel that senses cold stimuli and menthol. | 2002-03-08 |
|
| Identification of a cold receptor reveals a general role for TRP channels in thermosensation. | 2002-03-07 |
|
| Neurobiology: a cool ion channel. | 2002-03-07 |
|
| The dark side of marketing seemingly "Light" cigarettes: successful images and failed fact. | 2002-03 |
|
| Specificity of cold thermotransduction is determined by differential ionic channel expression. | 2002-03 |
|
| Neuroscience. How neurons know that it's c-c-c-c-cold outside. | 2002-02-22 |
|
| Transdermal drug delivery of imipramine hydrochloride. I. Effect of terpenes. | 2002-02-19 |
|
| Sensory and physiologic effects of menthol and non-menthol cigarettes with differing nicotine delivery. | 2002-01-29 |
|
| Factors affecting the resolution of dl-menthol by immobilized lipase-catalyzed esterification in organic solvent. | 2002-01-16 |
|
| Topical mononitrate treatment in patients with anal fissure. | 2002-01 |
|
| In vitro skin permeation of morphine hydrochloride during the finite application of penetration-enhancing system containing water, ethanol and l-menthol. | 2002-01 |
|
| Effect of the vesicular-arbuscular mycorrhizal (VAM) fungus Glomus fasciculatum on the essential oil yield related characters and nutrient acquisition in the crops of different cultivars of menthol mint (Mentha arvensis) under field conditions. | 2002-01 |
|
| Penetration enhancing effect of menthol on the percutaneous flux of nicardipine hydrochloride through excised rat epidermis from hydroxypropyl cellulose gels. | 2002 |
|
| Measurements by gas chromatography/pyrolysis/mass spectrometry: fundamental conditions in (2)H/(1)H isotope ratio analysis. | 2002 |
|
| Metabolism of (R)-(+)-pulegone in F344 rats. | 2001-12 |
|
| Fullerene modified supported lipid membrane as sensitive element of sensor for odorants. | 2001-12 |
|
| Smoking among Asian American and Hawaiian/Pacific Islander youth: data from the 2000 National Youth Tobacco Survey. | 2001-11-27 |
|
| Pulmonary peptide delivery: effect of taste-masking excipients on leuprolide suspension metered-dose inhalers. | 2001-11 |
|
| Systematic studies on structure and physiological activity of cyclic alpha-keto enamines, a novel class of "cooling" compounds. | 2001-11 |
|
| Smoking and pregnancy outcome among African-American and white women in central North Carolina. | 2001-11 |
|
| Effect of Mentha x piperita essential oil and monoterpenes on cucumber root membrane potential. | 2001-11 |
|
| Menthone and isomenthone biosynthesis in Pelargonium tomentosum Jacq. | 2001 |
|
| Final report on the safety assessment of Mentha Piperita (Peppermint) Oil, Mentha Piperita (Peppermint) Leaf Extract, Mentha Piperita (Peppermint) Leaf, and Mentha Piperita (Peppermint) Leaf Water. | 2001 |
|
| The effects of D and L isomers of menthol upon nasal sensation of airflow. | 1988-06 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bc34dc2a-fb50-4a58-8cdb-7d56426c6b37
Curator's Comment: maximum daily exposure on the skin of 0.0573 mg/kg/day
https://www.ncbi.nlm.nih.gov/pubmed/18640220
2.5% of RACEMENTHOL apply to affected area not more than 3 to 4 times daily
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25065786
After the d-menthol exposure (2.0 g in the 600 ml culture medium), the dry weight of the Microcystis aeruginosa FACHB-905 cells gradually decreased; the decrease in the dry weight after 5d exposure was 29, 12, and 2 mgL(-1) when the initial cell densities were 1.4×10(7), 1.2×10(6), and 2.9×10(5) cellmL(-1), respectively.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:34:50 GMT 2025
by
admin
on
Mon Mar 31 17:34:50 GMT 2025
|
| Record UNII |
BZ1R15MTK7
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C860
Created by
admin on Mon Mar 31 17:34:50 GMT 2025 , Edited by admin on Mon Mar 31 17:34:50 GMT 2025
|
||
|
NCI_THESAURUS |
C245
Created by
admin on Mon Mar 31 17:34:50 GMT 2025 , Edited by admin on Mon Mar 31 17:34:50 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
236388
Created by
admin on Mon Mar 31 17:34:50 GMT 2025 , Edited by admin on Mon Mar 31 17:34:50 GMT 2025
|
PRIMARY | RxNorm | ||
|
2430
Created by
admin on Mon Mar 31 17:34:50 GMT 2025 , Edited by admin on Mon Mar 31 17:34:50 GMT 2025
|
PRIMARY | |||
|
100000092317
Created by
admin on Mon Mar 31 17:34:50 GMT 2025 , Edited by admin on Mon Mar 31 17:34:50 GMT 2025
|
PRIMARY | |||
|
DB00825
Created by
admin on Mon Mar 31 17:34:50 GMT 2025 , Edited by admin on Mon Mar 31 17:34:50 GMT 2025
|
PRIMARY | |||
|
BZ1R15MTK7
Created by
admin on Mon Mar 31 17:34:50 GMT 2025 , Edited by admin on Mon Mar 31 17:34:50 GMT 2025
|
PRIMARY | |||
|
15409
Created by
admin on Mon Mar 31 17:34:50 GMT 2025 , Edited by admin on Mon Mar 31 17:34:50 GMT 2025
|
PRIMARY | |||
|
CHEMBL470670
Created by
admin on Mon Mar 31 17:34:50 GMT 2025 , Edited by admin on Mon Mar 31 17:34:50 GMT 2025
|
PRIMARY | |||
|
DTXSID1022180
Created by
admin on Mon Mar 31 17:34:50 GMT 2025 , Edited by admin on Mon Mar 31 17:34:50 GMT 2025
|
PRIMARY | |||
|
62788
Created by
admin on Mon Mar 31 17:34:50 GMT 2025 , Edited by admin on Mon Mar 31 17:34:50 GMT 2025
|
PRIMARY | |||
|
C61809
Created by
admin on Mon Mar 31 17:34:50 GMT 2025 , Edited by admin on Mon Mar 31 17:34:50 GMT 2025
|
PRIMARY | |||
|
SUB08475MIG
Created by
admin on Mon Mar 31 17:34:50 GMT 2025 , Edited by admin on Mon Mar 31 17:34:50 GMT 2025
|
PRIMARY | |||
|
2216-51-5
Created by
admin on Mon Mar 31 17:34:50 GMT 2025 , Edited by admin on Mon Mar 31 17:34:50 GMT 2025
|
PRIMARY | |||
|
BZ1R15MTK7
Created by
admin on Mon Mar 31 17:34:50 GMT 2025 , Edited by admin on Mon Mar 31 17:34:50 GMT 2025
|
PRIMARY | |||
|
16666
Created by
admin on Mon Mar 31 17:34:50 GMT 2025 , Edited by admin on Mon Mar 31 17:34:50 GMT 2025
|
PRIMARY | |||
|
218-690-9
Created by
admin on Mon Mar 31 17:34:50 GMT 2025 , Edited by admin on Mon Mar 31 17:34:50 GMT 2025
|
PRIMARY | |||
|
6725
Created by
admin on Mon Mar 31 17:34:50 GMT 2025 , Edited by admin on Mon Mar 31 17:34:50 GMT 2025
|
PRIMARY | |||
|
m7175
Created by
admin on Mon Mar 31 17:34:50 GMT 2025 , Edited by admin on Mon Mar 31 17:34:50 GMT 2025
|
PRIMARY | Merck Index | ||
|
5662
Created by
admin on Mon Mar 31 17:34:50 GMT 2025 , Edited by admin on Mon Mar 31 17:34:50 GMT 2025
|
PRIMARY | |||
|
934
Created by
admin on Mon Mar 31 17:34:50 GMT 2025 , Edited by admin on Mon Mar 31 17:34:50 GMT 2025
|
PRIMARY | |||
|
1381709
Created by
admin on Mon Mar 31 17:34:50 GMT 2025 , Edited by admin on Mon Mar 31 17:34:50 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
|
||
|
|
RACEMATE -> ENANTIOMER |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|